Clinical Trial Update: Chemotherapy Related Anemia [Phase 2]

View source ↗

Summary

Amgen provided an update on a Phase 2 trial addressing chemotherapy-related anemia in patients with non-myeloid malignancies; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Snippet

Sponsor: Amgen | Conditions: Anemia, Non-Myeloid Malignancies | Phase 2 | Status: COMPLETED